Logo image of YAR.OL

YARA INTERNATIONAL ASA (YAR.OL) Stock Fundamental Analysis

OSL:YAR - Euronext Oslo - NO0010208051 - Common Stock - Currency: NOK

385  -3.2 (-0.82%)

Fundamental Rating

4

Overall YAR gets a fundamental rating of 4 out of 10. We evaluated YAR against 69 industry peers in the Chemicals industry. Both the profitability and the financial health of YAR get a neutral evaluation. Nothing too spectacular is happening here. YAR is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year YAR was profitable.
In the past year YAR had a positive cash flow from operations.
YAR had positive earnings in each of the past 5 years.
Each year in the past 5 years YAR had a positive operating cash flow.
YAR.OL Yearly Net Income VS EBIT VS OCF VS FCFYAR.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

YAR has a Return On Assets of 1.85%. This is comparable to the rest of the industry: YAR outperforms 59.42% of its industry peers.
Looking at the Return On Equity, with a value of 3.86%, YAR is in line with its industry, outperforming 59.42% of the companies in the same industry.
The Return On Invested Capital of YAR (6.87%) is better than 72.46% of its industry peers.
The Average Return On Invested Capital over the past 3 years for YAR is above the industry average of 6.10%.
Industry RankSector Rank
ROA 1.85%
ROE 3.86%
ROIC 6.87%
ROA(3y)5.28%
ROA(5y)4.52%
ROE(3y)11.06%
ROE(5y)9.6%
ROIC(3y)10.26%
ROIC(5y)9.83%
YAR.OL Yearly ROA, ROE, ROICYAR.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

With a Profit Margin value of 2.05%, YAR perfoms like the industry average, outperforming 55.07% of the companies in the same industry.
YAR's Profit Margin has declined in the last couple of years.
The Operating Margin of YAR (7.91%) is better than 66.67% of its industry peers.
In the last couple of years the Operating Margin of YAR has declined.
Looking at the Gross Margin, with a value of 27.32%, YAR is in line with its industry, outperforming 44.93% of the companies in the same industry.
YAR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.91%
PM (TTM) 2.05%
GM 27.32%
OM growth 3Y-15.9%
OM growth 5Y-3.81%
PM growth 3Y-66.57%
PM growth 5Y-53.53%
GM growth 3Y-0.02%
GM growth 5Y-0.33%
YAR.OL Yearly Profit, Operating, Gross MarginsYAR.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

YAR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for YAR remains at a similar level compared to 1 year ago.
YAR has less shares outstanding than it did 5 years ago.
The debt/assets ratio for YAR is higher compared to a year ago.
YAR.OL Yearly Shares OutstandingYAR.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
YAR.OL Yearly Total Debt VS Total AssetsYAR.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

YAR has an Altman-Z score of 2.74. This is not the best score and indicates that YAR is in the grey zone with still only limited risk for bankruptcy at the moment.
YAR has a better Altman-Z score (2.74) than 69.57% of its industry peers.
The Debt to FCF ratio of YAR is 8.76, which is on the high side as it means it would take YAR, 8.76 years of fcf income to pay off all of its debts.
YAR's Debt to FCF ratio of 8.76 is fine compared to the rest of the industry. YAR outperforms 63.77% of its industry peers.
A Debt/Equity ratio of 0.52 indicates that YAR is somewhat dependend on debt financing.
YAR has a Debt to Equity ratio (0.52) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 8.76
Altman-Z 2.74
ROIC/WACC0.81
WACC8.49%
YAR.OL Yearly LT Debt VS Equity VS FCFYAR.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 1.90 indicates that YAR should not have too much problems paying its short term obligations.
YAR has a Current ratio (1.90) which is comparable to the rest of the industry.
A Quick Ratio of 0.96 indicates that YAR may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.96, YAR is in line with its industry, outperforming 42.03% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.9
Quick Ratio 0.96
YAR.OL Yearly Current Assets VS Current LiabilitesYAR.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

4

3. Growth

3.1 Past

YAR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 175.00%, which is quite impressive.
Measured over the past years, YAR shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -11.01% on average per year.
The Revenue has decreased by -2.88% in the past year.
YAR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.52% yearly.
EPS 1Y (TTM)175%
EPS 3Y-22.66%
EPS 5Y-11.01%
EPS Q2Q%380.95%
Revenue 1Y (TTM)-2.88%
Revenue growth 3Y-5.85%
Revenue growth 5Y1.52%
Sales Q2Q%10.55%

3.2 Future

The Earnings Per Share is expected to decrease by -11.73% on average over the next years. This is quite bad
YAR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.71% yearly.
EPS Next Y76.67%
EPS Next 2Y35.44%
EPS Next 3Y17.28%
EPS Next 5Y-11.73%
Revenue Next Year6.33%
Revenue Next 2Y2.5%
Revenue Next 3Y2.43%
Revenue Next 5Y2.71%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
YAR.OL Yearly Revenue VS EstimatesYAR.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
YAR.OL Yearly EPS VS EstimatesYAR.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 15.03, which indicates a correct valuation of YAR.
Based on the Price/Earnings ratio, YAR is valued a bit cheaper than the industry average as 78.26% of the companies are valued more expensively.
YAR's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.30.
A Price/Forward Earnings ratio of 11.98 indicates a reasonable valuation of YAR.
75.36% of the companies in the same industry are more expensive than YAR, based on the Price/Forward Earnings ratio.
YAR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.03
Fwd PE 11.98
YAR.OL Price Earnings VS Forward Price EarningsYAR.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

YAR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. YAR is cheaper than 81.16% of the companies in the same industry.
YAR's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. YAR is cheaper than 72.46% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.74
EV/EBITDA 6.17
YAR.OL Per share dataYAR.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300 400 500

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
YAR's earnings are expected to grow with 17.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.2
PEG (5Y)N/A
EPS Next 2Y35.44%
EPS Next 3Y17.28%

2

5. Dividend

5.1 Amount

YAR has a Yearly Dividend Yield of 1.29%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.99, YAR has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.35, YAR's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.29%

5.2 History

The dividend of YAR decreases each year by -8.80%.
Dividend Growth(5Y)-8.8%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

YAR pays out 41.38% of its income as dividend. This is a bit on the high side, but may be sustainable.
The Dividend Rate of YAR has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP41.38%
EPS Next 2Y35.44%
EPS Next 3Y17.28%
YAR.OL Yearly Income VS Free CF VS DividendYAR.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B
YAR.OL Dividend Payout.YAR.OL Dividend Payout, showing the Payout Ratio.YAR.OL Dividend Payout.PayoutRetained Earnings

YARA INTERNATIONAL ASA

OSL:YAR (7/11/2025, 7:00:00 PM)

385

-3.2 (-0.82%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)04-25 2025-04-25/bmo
Earnings (Next)07-18 2025-07-18/bmo
Inst Owners42.41%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap98.07B
Analysts65.19
Price Target368.9 (-4.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.29%
Yearly Dividend4.77
Dividend Growth(5Y)-8.8%
DP41.38%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.75%
Min EPS beat(2)-47.21%
Max EPS beat(2)37.7%
EPS beat(4)3
Avg EPS beat(4)19.35%
Min EPS beat(4)-47.21%
Max EPS beat(4)50.14%
EPS beat(8)4
Avg EPS beat(8)40.78%
EPS beat(12)6
Avg EPS beat(12)23.78%
EPS beat(16)7
Avg EPS beat(16)11.92%
Revenue beat(2)1
Avg Revenue beat(2)-1.57%
Min Revenue beat(2)-3.34%
Max Revenue beat(2)0.19%
Revenue beat(4)1
Avg Revenue beat(4)-2.83%
Min Revenue beat(4)-4.86%
Max Revenue beat(4)0.19%
Revenue beat(8)1
Avg Revenue beat(8)-8.1%
Revenue beat(12)2
Avg Revenue beat(12)-4.97%
Revenue beat(16)4
Avg Revenue beat(16)-3.46%
PT rev (1m)1.58%
PT rev (3m)3.32%
EPS NQ rev (1m)7.46%
EPS NQ rev (3m)27.63%
EPS NY rev (1m)0%
EPS NY rev (3m)0.56%
Revenue NQ rev (1m)2.05%
Revenue NQ rev (3m)-0.33%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.48%
Valuation
Industry RankSector Rank
PE 15.03
Fwd PE 11.98
P/S 0.68
P/FCF 20.74
P/OCF 6.22
P/B 1.29
P/tB 1.45
EV/EBITDA 6.17
EPS(TTM)25.62
EY6.65%
EPS(NY)32.14
Fwd EY8.35%
FCF(TTM)18.56
FCFY4.82%
OCF(TTM)61.94
OCFY16.09%
SpS563.5
BVpS298.42
TBVpS264.83
PEG (NY)0.2
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.85%
ROE 3.86%
ROCE 8.99%
ROIC 6.87%
ROICexc 7.05%
ROICexgc 7.58%
OM 7.91%
PM (TTM) 2.05%
GM 27.32%
FCFM 3.29%
ROA(3y)5.28%
ROA(5y)4.52%
ROE(3y)11.06%
ROE(5y)9.6%
ROIC(3y)10.26%
ROIC(5y)9.83%
ROICexc(3y)11.17%
ROICexc(5y)10.65%
ROICexgc(3y)12.02%
ROICexgc(5y)11.5%
ROCE(3y)13.48%
ROCE(5y)12.99%
ROICexcg growth 3Y-20.87%
ROICexcg growth 5Y0.34%
ROICexc growth 3Y-20.66%
ROICexc growth 5Y0.45%
OM growth 3Y-15.9%
OM growth 5Y-3.81%
PM growth 3Y-66.57%
PM growth 5Y-53.53%
GM growth 3Y-0.02%
GM growth 5Y-0.33%
F-Score6
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 8.76
Debt/EBITDA 1.8
Cap/Depr 104.6%
Cap/Sales 7.7%
Interest Coverage 4.23
Cash Conversion 72%
Profit Quality 161.03%
Current Ratio 1.9
Quick Ratio 0.96
Altman-Z 2.74
F-Score6
WACC8.49%
ROIC/WACC0.81
Cap/Depr(3y)107.36%
Cap/Depr(5y)98.34%
Cap/Sales(3y)6.55%
Cap/Sales(5y)6.27%
Profit Quality(3y)1242.99%
Profit Quality(5y)807.54%
High Growth Momentum
Growth
EPS 1Y (TTM)175%
EPS 3Y-22.66%
EPS 5Y-11.01%
EPS Q2Q%380.95%
EPS Next Y76.67%
EPS Next 2Y35.44%
EPS Next 3Y17.28%
EPS Next 5Y-11.73%
Revenue 1Y (TTM)-2.88%
Revenue growth 3Y-5.85%
Revenue growth 5Y1.52%
Sales Q2Q%10.55%
Revenue Next Year6.33%
Revenue Next 2Y2.5%
Revenue Next 3Y2.43%
Revenue Next 5Y2.71%
EBIT growth 1Y140.56%
EBIT growth 3Y-20.82%
EBIT growth 5Y-2.34%
EBIT Next Year149.37%
EBIT Next 3Y35.87%
EBIT Next 5Y12.96%
FCF growth 1Y-69.97%
FCF growth 3Y-28.42%
FCF growth 5Y-24.89%
OCF growth 1Y-39.59%
OCF growth 3Y-2.93%
OCF growth 5Y-7.58%